In turn, in a study focusing on pasireotide (SOM230), it was shown that it can affect angiogenesis processes and inhibit cell proliferation in pituitary adenomas secreting adrenocorticotropic hormone (ACTH). Here, POMC is linked to pituitary gland adenoma.